Sedation with intravenous midazolam in the pediatric intensive care unit

Clinical Pediatrics

Volumn 36, Issue 8, 1997, Pages 449-454

  Notterman, Daniel A ^a,b  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; BENZYL ALCOHOL; DIAZEPAM; LORAZEPAM; MIDAZOLAM;

ADOLESCENT; ADULT; APNEA; ARTICLE; ARTIFICIAL VENTILATION; BURN; CHILD; CRITICAL ILLNESS; DRUG SAFETY; DRUG WITHDRAWAL; ENDOTRACHEAL INTUBATION; HUMAN; HYPOTENSION; INFANT; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NEWBORN CARE; PEDIATRIC ANESTHESIA; RESPIRATORY FAILURE; SEDATION;

EID: 0030861666     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992289703600803     Document Type: Article

References (29)

1. Marx CM, Rosenberg DI, Ambuel B, et al. Pediatric intensive care sedation: survey of fellowship training programs. Pediatrics. 1993;91:369-378.
2. Rosen DA, Rosen KR. Midazolam for sedation in the paediatric intensive care unit. Intensive Care Med. 1991; 17:S15-S19.
3. McCready M, Greenwald BM, Scolavino J, et al. A prospective evaluation of unplanned endotracheal extubations in a pediatric intensive care unit. Crit Care Med. 1994;22:A 154 [abstract].
4. Reves JG, Fragen RJ, Vinik HR, et al. Midazolam: pharmacology and uses. Anesthesiology. 1985;62:310-324.
5. Mathews HML, Carson IW, Lyons SM, et al. A pharmacokinetic study of midazolam in paediatric patients undergoing cardiac surgery. Br J Anaesth. 1988;61:302-307.
6. Hartwig S, Roth B, Theisohn M. Clinical experience with continuous intravenous sedation using midazolam and fentanyl in the paediatric intensive care unit. Eur J Pediatr. 1991;150:784-788.
7. Johnston S, Notterman DA, McLaughlin G. Accumulation of α-hydroxymidazolam, an active metabolite, in critically ill children receiving IV infusion of midazolam. Pediatr Res. 1993;33: 35A [abstract].
8. Burtin P, Daoud P, Jacqz-Aigrain E, et al. Hypotension with midazolam and fentanyl in the newborn. Lancet. 1991;337:1545-1546.
9. Jacqz-Aigrain E, Daoud P, Burtin P, et al. Pharmacokinetics of midazolam during continuous infusion in critically ill neonates. Eur J Pharmacol. 1992;42:329-332.
10. Lloyd-Thomas AR, Booker PD. Infusion of midazolam in paediatric patients after cardiac surgery. Br J Anaesth. 1986;58:1109-1115.
11. Hughes J, Gill A, Leach HJ, et al. A prospective study of the adverse effects of midazolam on withdrawal in critically ill children. Acta Paediatr. 1994;83:1194-1199.
12. Tobias JD, Rasmussen GE. Pain management and sedation in the pediatric intensive care unit. Pediatr Clin North Am. 1994a;41:1269-1292.
13. Booker PD, Beechey A, Lloyd-Thomas AR. Sedation for children requiring artificial ventilation using an infusion of midazolam. Br J Anaesth. 1986;58: 1104-1108.
14. Patterson D, Carrigan L, Questad KA, et al. Posttraumatic stress disorder in hospitalized patients with burn injuries. J Burn Care Rehabit. 1990; 39:191-192.
15. Sheridan RL, McKettrick M, Bacha G, et al. Midazolam infusion in pediatric patients with burns who are undergoing mechanical ventilation. J Burn Care Rehabil. 1994;15:515-518.
16. Jacqz-Aigrain E, Daoud P, Burtin P, et al. Placebo-controlled trial of midazolam sedation in mechanically ventilated newborn babies. Lancet. 1994;344:646-650.
17. Bergman I, Steeves M, Burckart G, et al. Reversible neurologic abnormalities associated with prolonged intravenous midazolam and fentanyl administration. J Pediatr. 1991;119: 644-649.
18. Sury MRJ, Billingham I, Russell GN, et al. Acute benzodiazepine withdrawal syndrome after midazolam infusions in children. Crit Care Med. 1992; 17:301-302 [Abstract].
19. Coffey B, Shader RI, Greenblatt DJ. Pharmacokinetics of benzodiazepines and psychostimulants in children. J Clin Psychopharmacol. 1983;3:217-225.
20. Vree TB, Shimoda M, Driessen JJ, et al. Decreased plasma albumin concentration results in increased volume of distribution and decreased elimination of midazolam in intensive care patients. Clin Pharmacol Ther. 1989; 46:537-544.
21. Silvasi DL, Rosen DA, Rosen KR. Midazolam infusion for sedation in the pediatric intensive care unit. Anesth Analg. 1988;67:286-288.
22. Ambuel B, Hamlett KW, Marx CM, Blumer JL. Assessing distress in pediatric intensive care environments: the COMFORT scale. J Pediatr Psych. 1992;17:95-109.
23. Marx CM, Smith PG, Lowrie LH, et al. Optimal sedation of mechanically ventilated paediatric critical care patients. Crit Care Med. 1994;22:163-170.
24. Jacqz-Aigrain E, Wood C, Robieux I. Pharmacokinetics of midazolam in critically ill neonates. Eur J Pharmacol. 1990;39:191-192.
25. Burtin P, Jacqz-Aigrain E, Girard P, et al. Population pharmacokinetics of midazolam in neonates. Clin Pharmacol Ther. 1994;56:615-625.
26. Tobias JD, Deshpande JK, Gregory DF. Outpatient therapy of iatrogenic drug dependency following prolonged sedation in the pediatric intensive care unit. Intensive Care Med. 1994b;20:504-507.
27. Tobias JD, Deshpande JK, et al. Pentobarbital sedation for patients in the pediatric intensive care unit. South Med J. 1995;88:290-294.
28. Brown WJ, Buist NR, Gipson HT, et al. Fatal benzyl alcohol poisoning in a neonatal intensive care unit [letter]. Lancet. 1982;1:1250.
29. Hiller JL, Benda GI, Raazatzad M, et al. Benzyl alcohol toxicity: impact on mortality and intraventricular hemorrhage among very-low-birth-weight infants. Pediatrics. 1986;77:500-506.